Tag: QLOSI

Presbyopia is finally meeting its match in-clinic with Qlosi™ presbyopia eye drops (pilocarpine 0.4%), offering a practical, performance-based option alongside glasses, contact lenses, and surgery. In this episode, Dr. Jennifer Lyerly and Dr. Derek Cunningham discuss how to position presbyopia drops for success, including who to treat, how to dose, what to say chairside, and why athletes appreciate the functional freedom.

In this episode of The 4-Eyed Professor Podcast, Dr. Chris Lievens sits down with Dr. Janelle Davison to discuss Qlosi™, a pilocarpine eye drop specifically formulated for presbyopia treatment. Their conversation explores how the drop’s performance, convenience, and customization can enhance patient care while supporting the clinical and business objectives of modern optometric practices.

Presbyopia is a natural, age-related condition affecting 128 million worldwide, often addressed  with traditional solutions like reading glasses or progressive lenses. However, a groundbreaking  alternative is emerging: QLOSI™, a new presbyopia treatment featuring a 0.4% pilocarpine  hydrochloride ophthalmic solution.